After a protracted rough patch—which has included layoffs, partnership terminations and lawsuits—San Francisco’s Nektar ...

But Exela had upgraded its manufacturing technology — and not just on the floor of its 600-person plant in Lenoir. Exela had ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the ...

Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...

Big Pharma firm GSK plans to invest up to $800 million to expand its manufacturing operations in Pennsylvania and create 200 ...

The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, Roche and Dyno expanded ...

Medical device maker Baxter said on Thursday it expects to restart the highest-throughput intravenous solutions manufacturing ...

A part of the capex is planned for the domestic market while some of it would also go into the U.S. business, the chairperson ...

Medical device maker Baxter International said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by ...

Lyfius Pharma invests Rs. 2,500 crore with PLI scheme for its flagship penicillin-G facility at Kakinada, AP: Our Bureau, Bengaluru Wednesday, October 30, 2024, 12:50 Hrs [IST] Ly ...

Q3 2024 Earnings Conference Call November 4, 2024 9:00 AM ETCompany ParticipantsDavid Zaccardelli - President and ...